Abstract
Atezolizumab (Tecentriq(R)), a fully humanized, monoclonal anti-programmed cell death ligand-1 (PD-L1) antibody, is the first immune checkpoint inhibi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
